Stanley-Laman Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Stanley-Laman Group’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,269	Closed	-$68K	–	379
2016 Q1	$68K	Sell	11,269 -62,593	-85%	-$323K	0.01%	286
2015 Q4	$394K	Sell	73,862 -8,397	-10%	-$42.1K	0.07%	247
2015 Q3	$332K	Sell	82,259 -93,561	-53%	-$423K	0.07%	240
2015 Q2	$863K	Sell	175,820 -72,136	-29%	-$333K	0.16%	154
2015 Q1	$1M	Sell	247,956 -24,331	-9%	-$95.7K	0.18%	136
2014 Q4	$1.06M	Hold	272,287	–	–	0.2%	120
2014 Q3	$1.01M	Sell	272,287 -36,632	-12%	-$128K	0.2%	130
2014 Q2	$1.06M	Sell	308,919 -9,762	-3%	-$31.4K	0.19%	127
2014 Q1	$1.1M	Buy	318,681 +251,538	+375%	+$883K	0.19%	140
2013 Q4	$226K	Buy	+67,143	New	+$237K	0.05%	194

Other funds holding CEMI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCCM

Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TAM

Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stanley-Laman Group's CEMI Position: Q2 2016 in Review

Stanley-Laman Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2016, closing a stake of 11,269 shares — an estimated $68K sold.

Stanley-Laman Group first reported a position in CEMI in Q4 2013 and held it in 10 quarters. The position peaked at $1.1M in Q1 2014. 26 funds tracked by Wall St. Rank hold CEMI as of Q2 2016.

Stanley-Laman Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2016 after selling out during the quarter.
Stanley-Laman Group sold 11,269 Chembio diagnostics, Inc. shares in Q2 2016, an estimated $68K.
Stanley-Laman Group first reported a position in Chembio diagnostics, Inc. in Q4 2013 and held it in 10 quarters.
Stanley-Laman Group's Chembio diagnostics, Inc. position peaked at $1.1M in Q1 2014.
26 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2016.

Based on Stanley-Laman Group's 13F filing for Q2 2016, filed 4 Aug 2016.